Right.
Ms. Black, one of your recommendations is:
Ensure legal access to cannabis products in all of its various forms and potencies, including but not limited to: herbal cannabis, capsules, tinctures, topicals, resins, finished edible products. Otherwise patients will continue to access them in the unregulated market. This move would bring federal policy in line with the recent Supreme Court ruling, R vs. Smith 2015.
Can you elaborate on that and maybe explain the reference to the Smith case?